Daniel Prieto‐Alhambra

20.1k citations

420 papers · 11.2k indexed · 6 hit papers · h-index 54

Impact in

Orthopedics and Sports Medicine top 0.2%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Rheumatology top 0.2%
- Osteoarthritis Treatment and Mechanisms

Papers in

Orthopedics and Sports Medicine 117
- Bone health and osteoporosis research 98
- Bone and Joint Diseases 31
Rheumatology 83
- Rheumatoid Arthritis Research and Therapies 43
- Osteoarthritis Treatment and Mechanisms 31

Co-authors: Cyrus Cooper Nigel Arden Andrew Judge Adolfo Díez‐Pérez M K Javaid Xavier Nogués Carlen Reyes David Culliford
Journals: Osteoporosis International (40 papers)Journal of Bone and Mineral Research (30 papers)Annals of the Rheumatic Diseases (22 papers)Osteoarthritis and Cartilage (20 papers)Lara D. Veeken (18 papers)
Partner nations: United Kingdom Spain Netherlands

In The Last Decade

Daniel Prieto‐Alhambra

398 papers receiving 11.0k citations

Hit Papers

6 papers align trajectories log scale

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia 2024 · 84 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 The Lancet Respiratory Medicine
2017 The Lancet
2016 Arthritis & Rheumatology
2015 Osteoporosis International
2015 Osteoarthritis and Cartilage
2013 Annals of the Rheumatic Diseases

Peers

Countries citing papers authored by Daniel Prieto‐Alhambra

Since Specialization

Citations

This map shows the geographic impact of Daniel Prieto‐Alhambra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Prieto‐Alhambra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Prieto‐Alhambra more than expected).

Fields of papers citing papers by Daniel Prieto‐Alhambra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Prieto‐Alhambra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Prieto‐Alhambra. The network helps show where Daniel Prieto‐Alhambra may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Prieto‐Alhambra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Prieto‐Alhambra Line = papers co-authored together Daniel Prieto‐Alhambra links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Secular Trends in the Use of Valproate‐Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study Pharmacoepidemiology and Drug Safety ·Paulose-Ram, Martí Català, Edward Burn, Xiao Deng, 悠子吉田, Katia Verhamme, 秀夫米沢, Talita Duarte‐Salles, Tommi Kauko, 基八木, G Moneftsis, Sarah Seager, Daniel Prieto‐Alhambra, Annika M. Jödicke, Albert Prats‐Uribe	2025	0
2	Ethnic disparities in COVID-19 mortality and cardiovascular disease in England and Wales between 2020-2022 Nature Communications ·Marta Pineda‐Moncusí, N. Neuville, Hoda Abbasizanjani, Heidi Hyte, Albert Prats‐Uribe, Johan H. Thygesen, Angela Wood, Christopher Tomlinson, Amitava Banerjee, Ashley Akbari, Antonella Delmestri, Laura C. Coates, Spiros Denaxas, Kamlesh Khunti, Gary S. Collins, Daniel Prieto‐Alhambra, Sara Khalid	2025	1
3	Longitudinal trajectories of polypharmacy in older people, and their association with the risk of mortality: a joint latent class model analysis of real-world data from the UK and the Netherlands Age and Ageing ·Sara Zamora‐Terol, Ross D. Williams, Raymond Comenzo, Edward Burn, Binbin Kang, Victoria Y. Strauss, Daniel Prieto‐Alhambra	2025	0
4	Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death Nature Communications ·Yunhe Wang, Binbin Su, Anju G, Nicola L. Barclay, Yaohua Tian, Chunxiao Li, Nicholas J. Wareham, Roger Paredes, Junqing Xie, Daniel Prieto‐Alhambra	2024	11
5	Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes Nature Communications ·Anju G, Junqing Xie, Danielle Newby, Clara Prats, Dipender Gill, María Gordillo‐Marañón, Daniel Prieto‐Alhambra, Martí Català, Albert Prats‐Uribe	2024	4
6	OA42 Effect of intra-articular corticosteroid injections for osteoarthritis on subsequent use of pain medications: an instrumental variable and propensity score analysis Lara D. Veeken ·Samuel Hawley, Albert Prats‐Uribe, Gulraj S. Matharu, Antonella Delmestri, Daniel Prieto‐Alhambra, Andrew Judge, Michael R. Whitehouse	2024	1
7	Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code Pharmacoepidemiology and Drug Safety ·John Tazare, Shirley Wang, Rosa Gini, Daniel Prieto‐Alhambra, Peter Arlett, Maria T. Semchuk, Caroline E Morton, John Logie, Jennifer Popovic, Katherine Donegan, Sebastian Schneeweiß, Ian Douglas, Anna Schultze	2024	2
8	Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study Age and Ageing ·Carlen Reyes, Danielle Newby, Berta Raventós, Katia Verhamme, Mees Mosseveld, Daniel Prieto‐Alhambra, Edward Burn, Talita Duarte‐Salles	2024	1
9	The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications Heart ·Q. Liu, Xintong Li, Raivo Kolde, Nhung TH Trinh, María T. Sánchez-Santos, Raymond Comenzo, Elena Roel, Carlen Reyes, Antonella Delmestri, Hedvig Nordeng, Anneli Uusküla, Talita Duarte‐Salles, Clara Prats, Daniel Prieto‐Alhambra, Annika M. Jödicke, Martí Català	2024	20
10	Long-term risk of psychiatric disorder and psychotropic prescription after SARS-CoV-2 infection among UK general population Nature Human Behaviour ·Yunhe Wang, Binbin Su, Junqing Xie, Clemente García‐Rizo, Daniel Prieto‐Alhambra	2024	15
11	IncidencePrevalence: An R package to calculate population‐level incidence rates and prevalence using theOMOPcommon data model Pharmacoepidemiology and Drug Safety ·Berta Raventós, Martí Català, 悠子吉田, Yuchen Guo, Adam Black, 保将野崎, Xintong Li, Chiho Maeda, Danielle Newby, Maria de Ridder, Gülden Kadooğlu Aydın, Talita Duarte‐Salles, Katia Verhamme, Peter R. Rijnbeek, Daniel Prieto‐Alhambra, Edward Burn	2023	8
12	Genetic risk and incident venous thromboembolism in middle‐aged and older adults following COVID‐19 vaccination Journal of Thrombosis and Haemostasis ·Junqing Xie, Albert Prats‐Uribe, María Gordillo‐Marañón, Victoria Y. Strauss, Dipender Gill, Daniel Prieto‐Alhambra	2022	4
13	Comorbidities in osteoarthritis (ComOA): a combined cross-sectional, case–control and cohort study using large electronic health records in four European countries BMJ Open ·Subhashisa Swain, 江录春, J. Runhaar, Andrea Dell’Isola, Aleksandra Turkiewicz, Danielle E Robinson, Victoria Y. Strauss, Christian Mallen, Chang‐Fu Kuo, Carol Coupland, Michael Doherty, Aliya Sarmanova, Daniel Prieto‐Alhambra, Martin Englund, Sita Bierma‐Zeinstra, Weiya Zhang	2022	6
14	Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50 Nature Communications ·Junqing Xie, Shuo Feng, Xintong Li, Ester Gea‐Mallorquí, Albert Prats‐Uribe, Daniel Prieto‐Alhambra	2022	12
15	Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans The Journal of Clinical Endocrinology & Metabolism ·Martina Recalde, Andrea Pistillo, Sergio Fernández‐Bertolín, Elena Roel, María Aragón, Heinz Freisling, Daniel Prieto‐Alhambra, Edward Burn, Talita Duarte‐Salles	2021	16
16	Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study Health Technology Assessment ·Danielle E Robinson, M. Sanni Ali, Victoria Y. Strauss, Sara Zamora‐Terol, Bo Abrahamsen, Nigel Arden, Yoav Ben‐Shlomo, Fergus Caskey, Cyrus Cooper, Daniel Dedman, Antonella Delmestri, Andrew Judge, M K Javaid, Daniel Prieto‐Alhambra	2021	3
17	Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting Health Technology Assessment ·Albert Prats‐Uribe, Spyros Kolovos, Klára Berencsi, Andrew Carr, Andrew Judge, Alan J. Silman, Nigel Arden, Irene Petersen, Ian Douglas, J. Mark Wilkinson, David W. Murray, José M Valderas, David Beard, Sarah E Lamb, M. Sanni Ali, Rafael Pinedo‐Villanueva, Victoria Y. Strauss, Daniel Prieto‐Alhambra	2021	5
18	Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain International Journal of Epidemiology ·Daniel Prieto‐Alhambra, Elisabet Balló, Ermengol Coma, Núria Mora, María Aragón, Albert Prats‐Uribe, Francesc Fina, Mència Benítez, Carolina Guiriguet, Mireia Fàbregas, Manuel Medina, Talita Duarte‐Salles	2020	21
19	Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study Pediatric Allergy and Immunology ·Marjolein Engelkes, Aulia Ilmiawati, Maria de Ridder, Elisabeth Svensson, Daniel Prieto‐Alhambra, Francesco Lapi, Carlo Giaquinto, Gino Picelli, Nada Boudiaf, Frank C. Albers, زهير عمريو, Sarah Cockle, Eric Bradford, Melissa K. Van Dyke, Robert Suruki, Peter R. Rijnbeek, Miriam Sturkenboom, Hettie M. Janssens, Katia Verhamme	2020	27
20	Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis: A Population‐Based Cohort Study Arthritis & Rheumatology ·Carlen Reyes, K.M. Leyland, George Peat, Cyrus Cooper, Nigel Arden, Daniel Prieto‐Alhambra Hit paper breakdown →	2016	348

About Daniel Prieto‐Alhambra

Daniel Prieto‐Alhambra is a scholar working on Orthopedics and Sports Medicine, Rheumatology, Surgery, Oncology and Internal Medicine, having authored 420 papers that have together received 11.2k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (98 papers), Bone health and treatments (66 papers), Hip and Femur Fractures (66 papers), Total Knee Arthroplasty Outcomes (43 papers), Rheumatoid Arthritis Research and Therapies (43 papers), Orthopaedic implants and arthroplasty (35 papers), Osteoarthritis Treatment and Mechanisms (31 papers) and Bone and Joint Diseases (31 papers). The work is most often cited by research in Orthopedics and Sports Medicine (2.6k citations), Rheumatology (1.9k citations), Surgery (4.6k citations), Geriatrics and Gerontology (292 citations) and Nephrology (441 citations). Daniel Prieto‐Alhambra has collaborated with scholars based in United Kingdom, Spain and Netherlands. Frequent co-authors include Cyrus Cooper, Nigel Arden, Andrew Judge, Adolfo Díez‐Pérez, M K Javaid, Xavier Nogués, Carlen Reyes, David Culliford, Antonella Delmestri and Andrew Carr. Their work appears in journals such as Osteoporosis International, Journal of Bone and Mineral Research, Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact